# Mechanically adaptive Mg-Ti composites guided by single-cell insights accelerate load-bearing bone regeneration via dual modulation of osteogenesis and osteoclastogenesis

**Authors:** Wanxin Zheng, Sirui Tian, Jiaxing Huo, Qiyue Zhang, Danning Wang, Zengqian Liu, Baohong Zhao, Yuzhong Gao, Zhefeng Zhang, Qiang Wang

PMC · DOI: 10.1016/j.bioactmat.2025.10.038 · Bioactive Materials · 2025-11-06

## TL;DR

A new Mg-Ti composite material helps regenerate load-bearing bone by balancing mechanical support and biological activity, promoting bone growth while controlling breakdown.

## Contribution

A novel Mg-Ti composite with dual modulation of osteogenesis and osteoclastogenesis, guided by single-cell insights, is introduced for load-bearing bone regeneration.

## Key findings

- Mg promotes MSC recruitment and osteogenesis while inhibiting osteoclast maturation.
- The Mg-Ti-1200 composite increased bone volume by 55% in vivo after 8 weeks.
- The composite's mechanical properties adapt over time to match natural bone.

## Abstract

The regeneration and repair of load-bearing bone defects require a delicate balance between mechanical stability and biological integration. Magnesium (Mg)-based materials are promising due to their bioactivity, but their rapid degradation often results in the premature loss of mechanical strength, which compromises their ability to provide structural support during the critical early stages of bone healing, particularly in load-bearing applications. To address this challenge, a Magnesium-Titanium (Mg-Ti) composite was designed, integrating the bioactivity of Mg with the mechanical stability of titanium (Ti). Single-cell RNA sequencing revealed that Mg selectively promoted Mesenchymal Stem Cells (MSCs) recruitment and osteogenic differentiation, while also arresting osteoclast precursors to retain a less differentiated state. These precursors secreted PDGF-BB, coupling osteogenesis with angiogenesis. The Ti scaffold, fabricated as a 3D-printed rhombic dodecahedron structure that mimicked trabecular bone, ensured mechanical support while allowing controlled Mg degradation. This design enabled the progressive adaptation of the composites' mechanical properties to those of natural bone over time, in accordance with Nielsen's law, thereby optimizing both short-term stability and long-term integration. Mg-Ti-1200 exhibited dual-regulatory effects of osteogenesis-osteoclastogenesis: enhancing MSCs osteogenesis via the PI3K-Akt pathway, while inhibiting osteoclast maturation through the PLCγ2-Calcineurin-NFATc1 pathway. In vivo, the Mg-Ti-1200 resulted in a 55 % increase in bone volume and exhibited mechanical properties comparable to those of natural bone after 8 weeks of implantation. This study presented a mechanism-guided biomaterial strategy that integrated both mechanical and biological optimization for the functional regeneration of load-bearing bone defects.

Image 1

•scRNA-seq revealed Mg selectively promotes MSCs recruitment and osteogenesis while inhibiting osteoclastogenesis.•Mg-Ti-1200 composite arrests osteoclasts' differentiation , promoting bone-vascular coupling through PDGF-BB.•Mg-Ti-1200 composite enables controlled degradation with gradual elastic modulus matching.

scRNA-seq revealed Mg selectively promotes MSCs recruitment and osteogenesis while inhibiting osteoclastogenesis.

Mg-Ti-1200 composite arrests osteoclasts' differentiation , promoting bone-vascular coupling through PDGF-BB.

Mg-Ti-1200 composite enables controlled degradation with gradual elastic modulus matching.

## Linked entities

- **Proteins:** pdgfbb (platelet derived growth factor subunit Bb), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), PLCG2 (phospholipase C gamma 2), ppp3ca.S (protein phosphatase 3, catalytic subunit, alpha isozyme S homeolog), NFATC1 (nuclear factor of activated T cells 1)
- **Chemicals:** Mg (PubChem CID 888), Ti (PubChem CID 23963)

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NFATC1 (nuclear factor of activated T cells 1) [NCBI Gene 4772] {aka NF-ATC, NF-ATc1.2, NFAT2, NFATc}, PLCG2 (phospholipase C gamma 2) [NCBI Gene 5336] {aka APLAID, FCAS3, PLC-IV, PLC-gamma-2}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** bone defects (MESH:D001847)
- **Chemicals:** Mg-Ti-1200 (-), Ti (MESH:D014025), Magnesium (MESH:D008274)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12639329/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12639329/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12639329/full.md

---
Source: https://tomesphere.com/paper/PMC12639329